Clearly, the only reason I own this stock from the very beginning, is that the mTOR inhibitor (pathway) has been approved by the FDA for two other cancer indications.. Otherwise, I wouldn't touch this...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.